BrainAurora Medical Technology (6681) announced that its indirect wholly-owned subsidiary in Macau has entered into a long-term strategic agreement with Kiang Wu Hospital to offer digital screening, assessment, training, and overall management services for cognitive impairment. The collaboration seeks to build a new health service model spanning hospitals, communities, and residences. Within Kiang Wu Hospital, both parties intend to establish a Brain Health Center powered by the 66Brain Science Brain Health Cloud Service platform, aiming to provide one-stop support from early detection to disease course follow-up for senior populations and pediatric patients with neurodevelopmental disorders.

According to the announcement, the arrangement focuses on localized data storage and compliance with Macau’s regulations. It is expected to accumulate relevant clinical and application data, strengthening research on diagnosing and treating cognitive functioning conditions. The cooperation also positions BrainAurora Medical Technology to expand its digital therapeutics solutions in the Guangdong-Hong Kong-Macau Greater Bay Area while contributing to local healthcare needs. The Company believes this marks a significant milestone in further developing and standardizing digital therapeutics applications for brain health services. Shareholders and potential investors are advised to exercise caution when trading in the Company’s shares.